Pure Global

Study of Intra-articular Allocetra in Knee Osteoarthritis - Trial NCT06233474

Access comprehensive clinical trial information for NCT06233474 through Pure Global AI's free database. This Phase 1/2 trial is sponsored by Enlivex Therapeutics Ltd. and is currently Recruiting. The study focuses on Osteoarthritis, Knee. Target enrollment is 160 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06233474
Phase 1/2
Recruiting
drug
Trial Details
ClinicalTrials.gov โ€ข NCT06233474
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Study of Intra-articular Allocetra in Knee Osteoarthritis
A Phase 1/2a Randomized, Double-Blind Placebo-controlled Study of Intra-articular Allocetra in Knee Osteoarthritis

Study Focus

Osteoarthritis, Knee

Allocetra

Interventional

drug

Sponsor & Location

Enlivex Therapeutics Ltd.

Afula,Haifa,Petach Tikva,Reแบ–ovot, Israel

Timeline & Enrollment

Phase 1/2

Jan 26, 2024

Feb 01, 2026

160 participants

Primary Outcome

Treatment-emergent adverse events and Serious adverse events following Allocetra-OTS injection

Summary

This is a double blind, randomized,multi-center study to evaluate the safety and efficacy of
 intra-articular administration of Allocetra compared to placebo in patients with symptomatic
 knee osteoarthritis.

ICD-10 Classifications

Chronic instability of knee
Injuries to the knee and lower leg
Gonarthrosis [arthrosis of knee]
Dislocation, sprain and strain of joints and ligaments of knee
Sprain and strain of other and unspecified parts of knee

Data Source

ClinicalTrials.gov

NCT06233474

Non-Device Trial